header logo image


Page 4«..3456..10..»

Archive for the ‘Stem Cell Tourism’ Category

UFO Religion the Ralians Know They’re ‘Quite Out There’ – VICE UK

Saturday, January 25th, 2020

"The only difference between us and anybody else is that we believe all life was created by the Elohim, who were extra-terrestrials visiting Earth from another planet," Glenn Carter, president of the British Ralian movement, explains to me. "The rest of our behaviour is the same as any other human being, or group."

The Ralian movement, known to many as a "UFO religion", started in France in the 1970s. Their prophet a French former journalist and pop star called Ral (born Claude Vorilhon) claims that the origins of all life on Earth were explained to him during an alien encounter in 1973. The message he was given by the visitors became the Ralian philosophy, which he released in books that include The Book Which Tells the Truth and Extraterrestrials Took Me to Their Planet.

The belief system is one that argues for personal and sexual freedom, love, science and technological advancement. Oh, and that humans were put here thousands of years ago by aliens (or "advanced humans from another planet", to be exact) as an experiment. Since then, Ral has led this "atheist religion" through social justice campaigns, televised debates and battles with bad press, amassing hundreds of thousands of devoted followers from Canada to Japan.

Glenn Carter. Photo by the author.

"We were created in the image of another humanity," Glenn tells me over a pint in Leigh-on-Sea, Essex, before comparing life on Earth to the Eden Project in Cornwall. "They monitor us and wish one day to return to share their scientific knowledge [...] I discovered the philosophy in a bookshop and contacted the organisation. Eventually, they asked me to run it here," he explains.

Outside of his beliefs, Glenn is an actor known for playing Jesus in the Broadway, West End and movie versions of Jesus Christ Superstar a career that took a hit when he accepted the presidency.

"It has affected my life incredibly through the bigotry of other people," says Glenn, now in his fifties. "I won't be employed by certain producers I was really on the rise as a West End actor in musical theatre; I was on Broadway, winning awards, appearing in films, and the whole thing completely stopped as soon as an actress I worked with said, 'He's the guy that believes in aliens and he runs the Ralian movement'"

The creators the Ralians believe in are known as the Elohim, which, according to the prophet Ral, means "those who came from the sky" in the original Hebrew it's translated from. In Christianity and Judaism, the word simply means "God", but there has been much debate and disagreement around the translation of the word. It does appear to be plural, which indicates it could possibly translate to "gods" as opposed to God.

This speculation about ancient astronauts isn't unique to Ralism. Books like Erich von Daniken's 1968 epic Chariots of the Gods? and The Spaceships of Ezekial, written by a NASA engineer named Josef F Blumrich in 1974, popularised theories that Earth was visited long ago by extraterrestrials, and that some of those visitations even appear in religious scriptures.

Unpacking and reinterpreting stories from the Old Testament concerns much early Ralian literature. According to Ral, the Bible and other holy books are full of alien encounters and messages, but they've been misinterpreted over time. With this in mind, they believe that the prophets from all other religions were actually preaching messages from the Elohim, too including Ral's alleged half-brothers Jesus, Mohammed and Buddha.

UK Ralians and the author (second from left) at a dinner celebrating the first encounter.

"I think the best thing about the Ralian movement is that it encourages people to be free. That's what drew me to it," says Jamie, an IT technician and recent convert, at one of their monthly meet-ups. He used to identify with Buddhist teachings, but his old Christian church said they were "bad spirituality". He tells me Ralians remind him of the Buddhists he's met, that "they are very kind and have inner peace The main criticism of Ralianism is its size. Because it's very small, it's seen as a cult. People are scared of it."

Jamie was introduced to Ralism by a veteran UK member named Sakina, while she was working as a stripper: "He came to me one night, and simply by the way I connected, and the tender way I made him feel welcome," she says, "he asked me, 'What do you feel about life?'"

The pair started talking meditation and ended up at Ralian philosophy, with Jamie eventually subscribing to the belief system.

Unlike Sakina, however, not all Ralians openly discuss their faith in the workplace take Karen, for instance, who found the movement in her late fifties: "I work for the Metropolitan Police Service, which is very diverse and encourages diversity, but I know that if I was to say where I was coming from, [some people] would find that quite difficult. And, to be honest, I don't think they need to know."

I ask what her family think about her beliefs. "When I first told my husband, he was absolutely fine with it he's an atheist himself," she says. "The only concern he had was that it might be a cult and would they be taking me away from him? Three years down the line, we're still together, nothing has changed."

What about her son? "He's 30 and finds it amusing. He doesn't believe in anything himself. When I told him about the Ralian movement he went online and saw all these things about sex orgies [laughs] For his mum to be involved with that kind of organisation was really funny to him. He takes it with a pinch of salt."

Sex and promiscuity have been associated with the sect for decades, salacious articles appearing in tabloid newspapers, "Ral's Girls" popping up in Playboy magazine. It's true that the philosophy promotes sexual freedom, but the members I speak to insist that sex is found in the movement no more than it is anywhere else.

"I guarantee that lots of people have had sex in the Ralian movement with people they've met in the Ralian movement," says Glenn. "But the same thing happens at Barclays bank, between teachers at high schools, or wherever. Nothing is organised by the Ralian movement. It would be a waste of time because we've got so many other things to discuss and do."

Sandra is a Swedish-born Ralian living in London. She works in the tourism business and was hosting the monthly meeting in her central London office space one Sunday morning. "It's been quite hard sometimes, in my relationship with my friends. They all felt it was so strange," she explains earnestly. "But the Ralian values have always been my values."

Sandra found the religion through her interest in musical theatre, a fan of Glenn's who decided to email him on a whim. Eight years later she is an active member, organising events and getting involved in Free Meditation campaigns around the UK.

It's difficult to find anything written about the community that doesn't dismissively brand it a "cult" old VICE coverage included. I ask Glenn how this feels. "It's offensive it's literally like using the N-word to describe a black person," he says, perhaps underestimating the weight of using "literally" in this comparison. "The word 'cult' means, in its original sense, 'system of religious worship'. So, Christianity is a cult because it's a system of religious worship. So is Judaism, Islam and every religion you can name! It's designed to colour people's opinions of you, but that's just their own stupid insecurities."

These thoughts are echoed by Tomi, a long-haired Ralian rocker who lives in Liverpool: "It's a way to discredit us, because the old religions and the establishment, they are afraid of this message. We are a true revolution in all aspects of life."

Tomi is the president of the Romanian Ralian branch and has appeared all over Romanian TV. When I first met him in London he embraced me passionately and said, "You are my brother," a metal Ralian symbol hanging from his neck. Shortly after, we stood in a circle with some other followers, closed our eyes and attempted to make contact with the Elohim. The "transmission" was somewhere between a guided meditation and a good old-fashioned prayer, and although we got no response from the Elohim, everybody was thankful afterwards.

Ralian pensioners in the garden in Norfolk. Photo: provided.

After early coverage of the movement and a multitude of TV interviews with their founder through the 1980s and 90s, the organisation could have slipped quietly out of the public eye. However, in 2002 they made international headlines when Dr Brigitte Boisselier a Ralian bishop with a PhD in Analytical Chemistry claimed the group had cloned a human baby. The movement are big advocates for cloning, setting up the organisation Clonaid in 1997, dedicated to their quest for immortality. "Ralians believe there is no afterlife at all," Glenn tells me. "The only afterlife is the one that science could create for you."

As the president of UK Ralians, Glenn appeared on TV a lot at that time to defend cloning from an ethical and philosophical standpoint. This claim, and the debates that followed, drew a lot of attention to the religion, and even inspired a piss-taking sketch on Saturday Night Live. "Cloning is happening all the time, every day," says Glenn, confidently. "The only difference between stem-cell therapies and reproductive human cloning is that, in stem-cell therapies, you end the life that is developing, you harvest the cells and you don't allow it to grow."

Dr Boisselier never provided proof that Clonaid had cloned baby "Eve", and at the time the whole saga was criticised as a hoax by both journalists and scientists. When asked, Glenn can't say for certain if it really happened either.

As well as Clonaid, Ralians also started an anti-FGM charity called Clitoraid, campaigned to rehabilitate the swastika (a symbol they use as their own, placed inside the star of David), staged topless protests for equality, supported gay Pride events worldwide and even tried to sue the Pope over child sexual abuse in the Vatican. Some of their tactics in the fight for social justice have, admittedly, not helped their reputation like the time they handed out 10,000 condoms to students in Montreal to protest the Catholic School Commission's decision to veto high school condom machines. However, this doesn't stop them from fighting the good fight. "Fuck the oppression that society puts on us," says Glenn.

When I ask about UFO encounters, some members come forward with their stories all fairly classic lights-in-the-sky anecdotes, but without the usual fear and bewilderment. "Each time, I had a huge sensation of warmth, and sometimes a little tear," Sakina tells me, wistfully. "To witness it was such a beautiful thing."

The Ralian idea that we're being watched from above isn't just one for religious circles; even scientists and astronomers have entertained the idea known as the "zoo hypothesis".

On my last visit to the group, we gather on the 13th of December at a restaurant in Londons Docklands, called Area 51 Tex Mex to celebrate the anniversary of the prophet's first alien encounter. We watch a video from one of their Happiness Academy events essentially a big Ralian get-together and, although the nudity in it probably doesn't help their "sex cult" reputation, I can't deny it looks way more fun than any Sunday service I've attended.

As well as being a "religion-for-atheists" where freedom reigns supreme, Ralism's lasting pull is also identified as its championing of science.

"I've always been into the science part of it," Sandra tells me. "Finding spirituality together with science really spoke to me." She then goes onto casually tell me that "evolution was disproved in 1993", citing Dr Michael Behe and his theory of Irreducible Complexity a theory positing that humanity is the result of intelligent design, and one that has been rejected by the majority of the scientific community.

As the meeting draws to a close, I ask how it feels to regularly watch their white-clad prophet, Ral, face laughter and ridicule from journalists and TV audiences. "For me, it is hard. We have all experienced that in some way," says Sandra. "We are quite 'out-there', and that makes people insecure. I just try to have compassion for the people that think in that way."

Ralism is not without its unanswered questions and ambiguities and its past isn't entirely unblemished, but which religion is? Where other spiritual groups have grown and (sometimes literally) died out, imploded or been abandoned, this philosophy is seemingly more robust. The movement may never entirely shake off their "sex cult" reputation or be taken seriously as a religion, but the members I meet don't seem to mind too much. In fact, they're all too happy and devoted to care.

@Jak_TH

Excerpt from:
UFO Religion the Ralians Know They're 'Quite Out There' - VICE UK

Read More...

Doctor’s Hospital focused on incorporation of AI and machine learning – EyeWitness News

Friday, January 17th, 2020

NASSAU, BAHAMAS Doctors Hospital has depriortized its medical tourism program and is now more keenly focused on incorporating artificial intelligence and machine learning in healthcare services.

Dr Charles Diggiss, Doctors Hospital Health System president, revealed the shift during a press conference to promote the 2020 Bahamas Business Outlook conference at Baha Mar next Thursday.

When you look at whats happening around us globally with the advances in technology its no surprise that the way companies leverage data becomes a game changer if they are able to leverage the data using artificial intelligence or machine learning, Diggiss said.

In healthcare, what makes it tremendously exciting for us is we are able to sensorize all of the devices in the healthcare space, get much more information, use that information to tell us a lot more about what we should be doing and considering in your diagnosis.

He continued: How can we get information real time that would influence the way we manage your conditions, how can we have on the backend the assimilation of this information so that the best outcome occurs in our patient care environment.

Diggiss noted while the BISX-listed healthcare provider is still involved in medical tourism, that no longer is a primary focus.

We still have a business line of medical tourism but one of the things we do know pretty quickly in Doctors Hospital is to deprioritize if its apparent that that is not a successful ay to go, he said.

We have looked more at taking our specialities up a notch and investing in the technology support of the specialities with the leadership of some significant Bahamian specialists abroad, inviting them to come back home.

He added: We have depriortized medical tourism even though we still have a fairly robust programme going on at our Blake Road facility featuring two lines, a stem cell line a fecal microbiotic line.

They are both doing quite well but we are not putting a lot of effort into that right now compared to the aforementioned.

See the rest here:
Doctor's Hospital focused on incorporation of AI and machine learning - EyeWitness News

Read More...

26 destinations in Europe that were ruined by tourists over the past decade – INSIDER

Friday, January 17th, 2020

A beach on Sardinia has taken the extreme step of charging for admission.

One of the world's most beautiful beaches, as many as 6,000 people visit La Pelosa in the northwest of the Italian island of Sardinia every day in the summer months.

To help stem the tourism tide, CNN reports officials in the nearby town of Stintino plan to start charging visitors admission. Mayor Antonio Diana said the charge is expected to be about 4, or $4.45, to help cut tourist numbers to roughly 1,500 visitors a day.

Overcrowding is an issue on beaches throughout Europe, like many spots on the Spanish island of Ibiza.

Sun. Sand. Music. And people, lots of people. Ibiza may be legendary for those things, but people still live there, too and not every resident wants to hear a thumping techno soundtrack 24/7 or wake up to people passed out in their garden, at least if a BBC story asking if the party is "over" for Ibiza is anything to go by. The Telegraph reports residents have even taken to the streets to protest the issue.

Crowds have been a feature of Munich's Oktoberfest for centuries.

Some numbers: Oktoberfest is the largest folk festival in the world, with more than six million visitors in 2019. At last year's edition of the annual event, 7.3 million steins of beer were guzzled, according to The Local Germany. There were also 45 reported sexual assaults, 263 physical injuries, 32 instances of someone using their beer mug as a weapon and 96,912 cases of someone attempting to steal a beer mug.

Shocking as those numbers are, The Local reports that they are all mostly down from 2018's figures.

Speaking of alcohol, Dublin is becoming increasingly packed.

There's growing concern about overtourism in Dublin, reports The Irish Times. The Sunday Times asked if Ireland has reached "peak tourism." The South China Morning Post goes further, saying: "The Irish capital is a drinker's paradise, but with the tourist hordes homing in, prices are shooting up and elbow space is going down."

Read more:
26 destinations in Europe that were ruined by tourists over the past decade - INSIDER

Read More...

Faculty Highlights: Recent Grants and Awards | Now – Drexel Now

Friday, January 17th, 2020

In this section,Drexel Quarterlyprovides an update on research funding, commercialization activity and faculty honors at Drexel, courtesy of the Office of the Provost. This update offers a snapshot of activity during the most recent terms.

Major Gifts, Honors and Recognitions

Olimipia Meucci, PhD, professor and chair of the Pharmacology & Physiology Department in the College of Medicine, and Margaret A. Wheatley, PhD, John M. Reid Professor in the School of Biomedical Engineering, Science and Health Systems, were awarded fellows of the National Academies of Inventors.

Dean of the College of Engineering and Distinguished Professor of Civil, Architectural and Environmental Engineering Sharon L. Walker, PhD, was elected Fellow of the American Association for the Advancement of Science (AAAS), the worlds largest multidisciplinary scientific society and publisher of leading research through itsSciencefamily of journals.

Peter A. Lewin, PhD, Richard B. Beard Distinguished University Professor in the School of Biomedical Engineering, Science and Health Systems,receivedthe 2019 IEEE Ultrasound,Frequency,andFrequencyControl SocietyAchievementAward.

The American Society for Engineering Education has awardedthe College of Engineering its Bronze ASEE Diversity Recognition Award, the highest level distributed during this, the first year of the ASEE Diversity Recognition Program. The program grew out of a Deans Diversity Pledge established by the society in June of 2018.The award placesCoEamong the nations leaders in inclusive education in recognition of a culture that supports underrepresented groups, a particular mission under the leadership of Sharon L. Walker, PhD, dean of the college.Some 82 universities across the country submitted applications for review that outlined a baseline support program for underrepresented groups; quantified policies, culture, and climate related to underrepresented groups; demonstrated initiatives and programs aimed at strengthening the K-12 pipeline to reduce barriers to engineering education access; and demonstrating an action plan focused on continual improvement.

MichelBarsoum, PhD, Distinguished Professor,andYuryGogotsi, PhD, Distinguished University and Charles T. and Ruth M. Bach Professor, both ofthe College of Engineering,have been jointly awarded the 2020 International Ceramics Prize from the World Academy of Ceramics for their work on MAX phases and their 2D derivativesMXenesdiscovered at Drexel in 2011. The prize is bestowed only every four years to recognize the highest achievements in ceramics science and technology. Just 20 scientists worldwide have previously received the prize.

AndrewMagenau, PhD, an assistant professor in the College of Engineering, has been selected as a 2019 PMSE Young Investigator by the Division of Polymeric Materials: Science and Engineering (PMSE) of the American Chemical Society. The award recognizes early stage researchers who have made significant contributions to their respective fields within Polymer Science and Engineering. Approximately 15 researchers are selected annually for the honor.

SuruchiSood, PhD, an associate professor inthe Dornsife School of Public Health, received the K. Everett M. Rogers Awardto honor outstandingcontributions to advancing the study and/or practice of public health communication at the American Public Health Association 2019 Annual Meeting.

Fengqing (Zoe) Zhang, PhD,an assistant professor in the College of Arts and Sciences,was elected president of the American Statistical Associations Philadelphia chapter.

The Bioko Biodiversity Protection Program, directed by Mary Katherine Gonder,PhD, professor in theCollege of Arts and Sciences,celebrated the official adoption of its Moka Research Center by the government of Equatorial Guinea. The research centerthe regions first scientific field station now serves as a management center for the Gran Caldera de Luba Scientific Reserve, a 200-square mile protected area with some of the most ecologically dense fauna and primate species in Africa.

Pamela Geller,PhD, associate professorin the College of Arts and Sciences,was named chairofthe Society of Behavioral Medicinesnew Womens Health topic area.

KevinMoseby, PhD, assistant teaching professor of sociology in the College of Arts and Sciences, was elected to the Science, Knowledge and Technology Council of the American Sociological Association.

Anne ConverseWillkomm, Goodwin College of Professional Studies Department Head of Graduate Studies and assistant clinicalprofessor, was appointed to the Board of Directors forWePAC(West Philadelphia Alliance for Children) to chair the Development Committee.

Stella Volpe, PhD, professor and chair of the Department of Nutrition Sciences in theCollege of Nursing and Health Professions,was selected as an honorary member ofCELAFISCS (Centro deEstudosdoLaboratoriodeAptidaoFiscicade Sao Caetano doSul) inSo Paulo,Brazil.

Rose AnnDiMaria-Ghalili,PhD, professor of nursing and assistant dean for interprofessional and collaborative research in the College of Nursing and Health Professions,was awardedfellow status through the health sciences section of theGerontologicalSociety of America.

WilliamLorman, PhD, assistant clinical professor in the College of Nursing and Health Professions,will be inductedas a Fellow in the American Academy of Nursing.

Lori Severino, EdD, assistant professor in the School of Education,was awarded the 2019 Council for Learning Disabilities Floyd G. Hudson award for outstanding service to the learning disabilities community. The award is given annually and honors a professional who works in a role outside the classroom for outstanding performance andcommitment to the field of learning disabilities.

NancySonger, PhD, Distinguished University Professor in the School of Education, received a 20192020 Fulbright U.S. Scholar Award to work with the Ministry of Science and Technology in Brasilia, Brazil, and the Science in School Program to promote elementary and secondary students problem-based and critical thinking in STEM fields across Brazil.

Sponsored Research

Distinguished University Professor and Dean of the Drexel University College of Nursing and Health Professions Laura N. Gitlin, PhD, will co-lead one of eight core groups of a newly funded research incubator comprised of 30 of the top research institutes in the United States. The $54.3 million grant given by the National Institute on Aging; the College of Nursing and Health Professions at Drexel University will receive $1.5 million of the grant award.

Evan Forman, PhD, (PI) professor in the College of Arts and Sciences, and co-investigators Meghan Butryn,PhD, associate professor in the College of Arts and Sciences; Adrienne Juarascio,PhD, assistant professor in the College of Arts and Sciences; and Stephanie Manasse,PhD, assistant research professorin the College of Arts and Sciences,received a $3.65 million grant from the National Institute for Diabetes and Digestive and Kidney Diseases for their project Mindfulness and Acceptance-Based Interventions for Obesity: Using a FactorialDesign to Identify the Most Effective Components.Juarascio, Forman and Manasse alsoreceived a $900,000 Small Business Innovation Research grant from the National Institutes of Health (NIH) to develop and commercialize a continuous smartphone-delivered, glucose monitoring-based treatment for eating disorders.

Yaghoob Farnam, PhD, an assistant professor in the College of Engineering, received a $266,000 award from the National Science Foundation (NSF) to develop a scalable lightweight aggregate manufacturing technology from waste coal combustion ash.

Rose AnnDiMaria-Ghalili,PhD, professor of nursing and assistant dean for interprofessional and collaborative research in the College of Nursing and Health Professions, and 23 faculty from nine Drexel and colleges and schools across with an interest in aging research from the cellular level to the society level have been awarded a $250,000 grant from Drexel Universitys Drexel Areas of Research Excellence (DARE). The one-year project Cell2Society Aging Research.net (Cell2Society) creates a novel ecosystem for the pursuit of use-inspired aging research from which to inform the role of Drexel University in an aging society.

Hualou Liang, PhD, professorinthe School of Biomedical Engineering, Science and Health Systems(PI), received a three-year $545,000Food and Drug Administration (FDA) contract to conduct a study entitled, Developing Tools based on Text Analysis and Machine Learning to Enhance Product Specific Guidance (PSG) Review Efficiency.

Kapil Dandekar, PhD, professor inthe College of Engineering, is the primary investigator on the inter-disciplinary project SCH: INT: Smart and Connected Health for Newborn Ventilation. The project was recently selected for funding by the National Institute of Biomedical Imaging and Bioengineering, a division of the NIH. The project's co-investigators include Anup Das, PhD, from the College of Engineering; Vineet Bhandari, MD, and EndlaAnday, MD, professors from the College of Medicine; and Westphal College of Media Arts & Design professor Genevieve Dion, who is an affiliate faculty member in the College of Engineering and director of the Center for Functional Fabrics; Kelly Joyce, PhD, professor in the College of Arts and Sciences. The project is funded at an anticipated $1.04 million over four years. The goal of the research is to develop a smart and connected health solution to unobtrusively and non-invasively monitor newborns, according to the project's abstract.

Gail Rosen, PhD, an associate professor in the College of Engineering, serves as the primary investigator on the project MRI: Proteus++: Enabling Data-Intensive Computing at Drexel University, recently funded by the NSF. The project is funded at $542,740 for three years. The Major Research Instrumentation Program (MRI) through NSF funds the acquisition of major scientific equipment at universities and STEM research organizations. This project will massively expand the data-intensive computational capabilities of Proteus, Drexel Universitys existing shared high-performance scientific CPU-only cluster, according to the project summary.This project is a collaborative effort that includes co-investigatorsAntoniosKontsos, PhD, an associate professor in the College of Engineering; Hasan Ayaz, PhD, an associate professor in the School of Biomedical Engineering, Science and Health Systems; andBrigitaUrbanc, PhD, acting associate department head for graduate studies and professor in the College of Arts and Sciences.

Jane Clougherty, ScD, an associate professor inthe Dornsife School of Public Health, was awarded a five-year $2.7 million R01 grant from the National Institute of Environmental Health Sciences.The grant, Pediatric Health and Extreme Weather Health Effects of Ambient Temperature (PHEW-HEAT), will be used to combine spatially and temporally resolved estimates of surface temperature with large statewide administrative clinical datasets.

Philip Massey, PhD, an associate professor in the Department of Community Health and Prevention attheDornsife School of Public Health,isthe lead investigator for a new $1.83 million, R01 grant designed to increaseHPVvaccination ratesamong adolescentsby educating parents through social media.

Maria T. Schultheis, PhD, vice provost of research and professor in the College of Arts and Sciences,was awarded a $2.1 million grant from the NIHfor her project UsingVirtualRealityDrivingSimulation toPredictDrivingOutcome afterBrainInjury.

Kelly Joyce,PhD, a professor in the College of Arts and Sciences,and her Drexel colleagues across sixcolleges andcenters were awarded a $1.038 million NIH grant for the project SCH: INT: Smart and Connected Health for Newborn Ventilation. The team will investigate the creation and use of smart textiles to monitor infants respiration while they are in emergency transport, such as an ambulance.

Naomi Goldstein, PhD, a professor in the College of Arts and Sciences, is co-investigator on a $500,000 grantled by the School District of Philadelphia to conduct research on the districts School Violence Prevention Program Project, funded by the Office of Community-Oriented Policing Services in the U.S. Department of Justice.

ZsofiaSzep, MD, an associate professor of medicine and medical director of the partnership comprehensive care practice in the College of Medicine, was awarded a five-year $2.5 million SAMHSA grant for Philadelphia Urban Health Collaborative for substance use disorder:Mobile services for prevention, engagement in care and treatment.

Dong Wang, PhD, an assistant professor in the College of Medicine, , Department of Neurobiology & Anatomy, was awarded a NIH grant ($1.5 million over four years) for A Raphe-Hippocampus Pathway for Regulation of Memory Specificity during Consolidation

NancySonger, PhD, Distinguished University Professor in the School of Education, is the principal investigator on a four-year $2.975 million grant awarded by the NSF DRK-12. The project is titledLife Right Here and Everywhere: Case Studies of Next GenerationScience Instructional, Assessment and Professional Development Materials Implemented in Two Diverse Middle School Settings.

Kristy Kelly, PhD, an assistant clinical professor in the School of Education,is part of an international team that is conducting a three-year, longitudinal, mixed methods study of changes in womens empowerment among ethnic minority women working inagriculture and tourism sectors in Son La and Lao Cai Provinces in Vietnam. The project, titledGender Responsive Equitable Agriculture and Tourism (GREAT) Longitudinal Study, is supported byAusAIDVietnam ($670,476). The research team includes faculty from Drexel, Vietnam National University,Luong Minh Phuong (Hanoi University), and Nga Ngo (Tay Bac University) and the University of Minnesota.

Originally posted here:
Faculty Highlights: Recent Grants and Awards | Now - Drexel Now

Read More...

Asia is where health investors are making money this year – Stockhead

Friday, January 17th, 2020

Asia is rising as a healthcare spender, matching incomes and the long-feared elderly population boom.

The region is a major part of a surge in health spending that is expected over the next few years, as rising lifestyle illnesses and ages combine just as incomes and health expectations are also lifting, according to a report from Deloitte.

For companies with a focus on Asia, such as contact lens maker Visioneering Technologies (ASX:VTI) or Green Whistle painkiller producer Medical Developments International (ASX:MVP), that bodes well as the private sector has money to spend and the inclination to spend it.

Deloitte says healthcare spending globally is expected to rise at a compound annual growth rate of 5 per cent in the years from 2019 until 2023.

It says spending in 2019 slowed, likely due to currency shifts and decelerating global economic growth, but big annual increases from the Middle East/Africa (7.4 per cent) and in Asia (7.1 per cent) are set to buoy the global healthcare sector in 2020.

In China, particularly in the Hainan province, as well as in Thailand, Singapore, and other Southeast Asian countries, medical tourism is a major growth area.

To meet rising demand from foreign patients, many private hospitals are planning to invest in expanding their medical facilities, the 2020 Global Health Care Outlook report said.

It estimated a compound annual growth rate of 29 per cent in the next decade.

In a broader effort to grow the industry, Chinas government launched the Hainan International Medical Tourism Pilot Zone Scheme in 2013 and issued several supporting policies in 2018 and 2019, the report said.

This zone focuses on providing high-end health services, including cancer and cardiovascular disease treatment and rehabilitation; assisted reproduction technology; health and well-being programs using both cutting-edge technologies and traditional Chinese medicine; cosmetic services; and retreat tourism.

In November, regenerative medicine play Admedus (ASX:AHZ) won approval from the Indian regulator for Cardiocel, thus opening up an annual market of 50 million cardiac patients (as well as the medical tourism market).

The Deloitte report makes the obvious point that providing geriatric healthcare is likely a key concern for governments and health systems.

Overall life expectancy is projected to increase from an estimated 73.7 years in 2018 to 74.7 years by 2023. The number of people aged over 65 will be more than 686 million, or 11.8 percent of the total population, it said.

The trend will be most noticeable in Japan, where the share of people aged 65+ is expected to reach almost 29 per cent by 2023; in Western Europe this is expected to be 22 per cent. Spending on the global geriatric care market (home health, remote patient monitoring, etcetera) will likely exceed $US1.4 trillion by 2023.

In December, Austrade senior advisor Stan Roche told Stockhead he believed aged care in China to be one of the growth areas within the health sector where Australia could offer expertise.

Companies like Compumedics (ASX:CMP), which deals in high-tech brain imaging devices, and biotech Neuroscientific Biopharmaceuticals (ASX:NSB) are likely to play well in the aged care sector as they can help catch, and in the latters case cure, age-related diseases like Alzheimers.

Those targeting Japan are naming geriatric care as a key reason. Stem cell play Regeneus (ASX:RGS) is looking at osteoarthritis and Japan is a key market, while Cellmid (ASX:CDY) said in mid-2019 Japan was going bonkers for its line of hair-loss products.

The news that lifestyle diseases are rising will be familiar to investors in the health industries, but for the uninitiated, Deloitte has outlined why:

Nearly 425 million people were living with diabetes in 2017; by 2045, that number is projected to increase by 48 per cent to 629 million, the report said.

China (114.4 million), India (72.9 million), and the United States (30.2 million) topped the list of people with diabetes in 2017 and are expected to retain those spots into 2045.

Lifestyle-related factors including smoking, poor diet, hypertension, obesity, and lack of physical activity contribute to many of the top 10 global causes of death.

As a result, Deloitte identified prevention as a key trend for 2020, as governments try to rein in later costs with earlier spending.

In Australia, Holista Colltech (ASX:HCT) is already targeting the obesity market in Asia with everything from diet noodles to low-calorie sugar, while GI Dynamics (ASX:GID) has a gastric stent that can help people lose weight, and deal with diabetes and sleep apnoea.

Continued here:
Asia is where health investors are making money this year - Stockhead

Read More...

Smart Luggage Market: Analysis and In-depth Study on Market Size Trends, Emerging Growth Factors and Forecasts to 2022 – Fusion Science Academy

Friday, January 17th, 2020

Overview:

The luggage industry is witnessing innovation driven by the addition of tracking system, automated locking, and Bluetooth features creating a niche smart luggage market. Owing to this, several luggage companies and crowd-funded start-ups are adding tech features to the luggage products to address the stagnant innovation. The term smart luggage is widely used for bags and suitcases with various tech-savvy features such as Wi-Fi hotspots, SIM cards, GPS, Bluetooth, RFID, built-in batteries, and digital scaling. The aim is not to just add features to the luggage, but to make it user-friendly in practical applications. These benefits are driving luggage companies to incorporate technology features into their offerings to stay in the ever-changing business world. The major luggage companies such as Bluesmart, Samsonite, and Delsey are investing in the incorporation of technology into their products and offer enhanced tech-savvy features to the customers.

Get Sample Copy Of The[emailprotected]https://www.trendsmarketresearch.com/report/sample/9822

Market Analysis:

According to Infoholic Research, the Smart Luggage market is expected to reach $2,353.2 million by 2022, growing at a CAGR of around 26.4%. Increasing airline travel & tourism, innovations in product design & quality, demand for IoT-based applications, and consumer shift towards leisure lifestyle are forcing organizations to focus on embedding the technology features into their traditional luggage. The increasing international travel and internet penetration are some of the major drivers for introducing technology applications in the luggage industry.

Technology Analysis:

Technology is the major boosting factor for smart luggage market. The major technology providers have joined hands with luggage manufacturers to offer innovative solutions, which enable the customers to enjoy the journey with maximum comfort such as luggage tracking, USB charging, digital scaling, and remote locking. New players are entering the market and key luggage companies are trying to acquire them to gain their technical knowledge for the betterment of their product portfolio. The technology market is further segmented into connectivity, sensors, SIM cards, USB charging, and others. In 2016, connectivity technology had a major share of the market and is expected to reach $898.0 million by 2022, growing at a CAGR of 26.7% during the forecast period 20162022.

Regional Analysis:

At present, the Americas is having the majority of the market share mainly due to the advancements in technology and its adoption. The market is witnessing prominent growth in the countries such as the US and Canada. Americas is followed by Asia Pacific. Regional government initiatives for developing smart city projects and increasing FDI for industrialization enhancement in the region are the main factors contributing to the market growth. Europe is spending hugely in the manufacturing industry, especially on raw materials and their use. The RoW region is expected to have a positive growth in the market, which will offer huge opportunities for key players to provide innovative solutions in the region.

Request For Report[emailprotected]https://www.trendsmarketresearch.com/report/discount/9822

Key Players:

The key players covered in the report are Samsonite, Delsey, Bluesmart, Raden, Away, Trunkster, and Lugloc.

Competitive Analysis:

The study covers and analyzes the Smart Luggage market. Bringing out the complete key insights of the industry, the report aims to provide an opportunity for players to understand the latest trends, current market scenario, government initiatives, and technologies related to the market. In addition, helps the venture capitalist in understanding the companies better and take informed decisions.

Benefits:

The report provides an in-depth analysis of the smart luggage market aiming to avoid luggage mishandling, reduce baggage check-in time for travelers & authorities in airports, and provide information for travelers regarding the journey. The report talks about distribution channel, technology, applications, and regions. With the information offered, key stakeholders can know about the major trends, drivers, investments, vertical players initiatives, and PPPs interest towards the adoption of technology into luggage industry. Further, the report provides details about the major challenges going to impact the market growth.

Key Stakeholders:

Device manufacturers, network providers, software providers, data security solution vendors, policy makers, standard development organizations, investor community, university researchers, blog writers, and technology magazines.

Make an Inquiry before [emailprotected]https://www.trendsmarketresearch.com/checkout/9822/Single

View original post here:
Smart Luggage Market: Analysis and In-depth Study on Market Size Trends, Emerging Growth Factors and Forecasts to 2022 - Fusion Science Academy

Read More...

The top 45 stories of the decade – ISRAEL21c

Monday, December 30th, 2019

Its only been 10 years, but in that time the world has been transformed. Social media has gone from angel of democracy to demon. Climate change has become something we can see with our own eyes. All over the world, established orders have been overturned.

In Israel, new technologies like auto-tech, fintech, AI and food-tech have emerged to dominate Israels high-tech scene, while Israels food scene has come of age as you can tell by the high number of accolades to Israeli restaurants rolling in. Israeli TV has also won its fair share of praise, spurring an unexpected new area of export.

In this decade, Israel lost one of its most internationally popular leaders, Shimon Peres; but women the world over got two strong new role models Israeli actor Gal Gadot, who stormed the world with her portrayal of Wonder Woman, and Netta, who swept Eurovision with her bubbly empowerment song, Toy.

Weve looked back through our archives to discover your favorite stories. Its an extraordinary journey that charts the emergence of Israels aid industry, the move toward veganism and alternative meats, and the growth of tourism to Israel from just 1.9 million tourists to Israel in 2010, to 4m. in 2019.

Some of the technologies we wrote about went on to huge success, some pivoted, and some notably Shai Agassis Better Place went out with an almighty bang.

Take a look through the decades and remember some of the highlights of every year.

2010

An IDF doctor tends to a patient at the field hospital in Haiti, January 23, 2010. Photo courtesy Israel Ministry of Foreign Affairs

One of the decades most iconic gadgets, Amazons Kindle e-reader, was largely developed in the heart of Israels high-tech center in Herzliya.

In June 2010, a professor from Bar Ilan University announced that he was developing a male contraceptive pill. His hope was that it would be out on the market within five years. While the idea created huge interest, the product ultimately never came to fruition.

Israel gained worldwide praise for the speed and efficiency with which it offered aid to Haiti in the wake of a catastrophic 7.0 magnitude earthquake that killed around 160,000 people. The field hospital set up by the Israel Defense Forces was one of the most advanced hospitals in Haiti. Five years later, Israel was still in Haiti helping rebuild the community. Haiti was the first time that the world really sat up and noticed Israeli humanitarian aid.

A breakthrough from Hadassahs Human Embryonic Stem Cell Research Center was poised to enable cultivating embryonic stem cells for treatments for disorders such as Parkinsons disease, diabetes and age-related macular degeneration. This later formed the basis for CellCure Neurosciences, currently developing OpRegen for treating dry AMD.

2011

The beaches of Tel Aviv. Photo by Shutterstock

Our top story of 2011 was on Vaxil Bio Therapeutics, which was developing a vaccine that could activate the bodys natural immune system to seek and destroy cancer cells. Since then, the company has completed a Phase I/II clinical trial in multiple myeloma patients, and is advancing toward clinical studies in additional solid tumor indications.

Yokneam-based Neuronix developed an electromagnetic stimulation system for treating moderate Alzheimers disease, allowing patients to regain faded cognitive skills. Though approved for use in Europe, Australia and Israel, in 2019 an FDA advisory panel decided that the benefits of the system did not outweigh the risks to patient health.

In June, we published a list of the 10 best beaches in Israel. Nine years later, the story continues to be one of our most popular, which for a country with as much beautiful coastline as Israels, isnt that surprising.

In May, we launched the first of a series of articles on hiking in Israel. The top 10 hikes in Israel was first, followed by water hikes, desert hikes, hikes in Jerusalem, and hikes in the Dead Sea.

2012

Tal-Yas trays catch every drop of dew. Photo: courtesy

To celebrate Israels 64th birthday, ISRAEL21c described 64 blue-and-white innovations with the potential to transform and enrich lives across the planet.

The US developer of skyTran chose Israel as the perfect place to pilot the software-guided personal transport pods that glide on a cushion of air. While the Tel Aviv project has yet to get off the ground, additional Israeli cities including Netanya and Eilat have since signed development deals with skyTran to upgrade public transportation.

This story about groundbreaking agricultural innovations from drip irrigation to drought-proof seeds proved so popular, and so important, that we updated it in 2019.

An amazing invention that turns pet droppings into harmless, odorless powder within seconds has developed into game-changing applications for human waste-management in the United Statesand Brazil.

2013

Pomegranate juice on sale at the Carmel Market. Photo by Anna Wachspress

The outright winner for story of the yearin 2013 though we could never completely understand why was our piece on 10 great reasons to love the pomegranate. Pomegranate, anyone?

In 2013, we began a new series on things to do for free in various cities around Israel. Our first story was an immediate hit and continues to be popular. We updated it earlier this year.

To celebrate Israels 65th birthday, we took a look at some of the incredible ways Israel is helping to look after our planet. Its still an impressive list.

When we reported on CartiHeal in 2013, the novel Israeli implant which provides a scaffold for the body to regenerate joint-protecting cartilage was already regarded as a major potential advance. It also featured in the top stories of 2016. Find out more below.

2014

The Iron Dome proved the unexpected hero of the 2014 war with Gaza. Photo by Shutterstock

From the Babysense baby breathing monitor to the Skysaver emergency evacuation device, this list compiled 18 potentially lifesaving technologies developed in Israel.

In 2014, the Iron Dome defense system emerged as the undisputed savior in Israel during the summer conflict with Gaza. Born out of necessity and Israeli chutzpah, the Iron Dome intercepts rockets, artillery and mortars headed for population centers. Sneak preview: Some of the prototype components were taken from a toy car.

Most of these unusual places to lay your head that we featured in this story including a yurt and a converted bus are still in business and popular with visitors looking for a different hospitality experience.

Medical devices and pharmaceuticals are a risky business and not all make it to market. But many of the exciting products anticipated in 2014 went on to successful clinical trials, such as Premia Spines TOPS alternative solution to spinal fusion surgery and CartiHeals implant for treating cartilage lesions in arthritic and non-arthritic joints.

2015

Is clean meat on the way? Photo by Shutterstock

This story exploded on the Internet, going viral within a day. It featured the work of nonprofit Modern Agriculture Foundation, which launched the worlds first feasibility study to determine how to create commercial tissue-engineered chicken breast. We featured the organization again in 2017, and it is still hard at work collaborating with academics and commercial companies to create a clean meat alternative.

We asked photographers across Israel to help us out with this gorgeous compilation of photographs to celebrate Israels 67th birthday.

3. 12 impossible ideas that Israelis turned into reality

Tell an Israeli that their idea is preposterous, and youve just given that inventor a reason to see it through. We loved this article, which highlights not only Israeli innovation, but the Israeli can-do attitude that takes an impossible idea irrigating crops in the desert, or a missile defense shield for an entire country and turns them into reality.

4. Israeli school builds cool classroom for ADHD teens

Our readers loved this story on a new classroom built at the Darca High School inKiryat Malachi, developed specially for children with attention and learning disorders. The room featured bouncy chairs made from yoga balls, walled off cubicles, desks on wheels, and a touch of the outdoor.

5. How well do you know Israel? The quiz

We knew it was going to be a tough one, but we were still surprised when virtually no-one managed to get a full 25 out of 25 questions right. You can still try this quiz. Will you get it right? Dont say you havent been warned!

2016

CartiHeal is advancing its implant for cartilage regeneration. Image by Natalia Budianska Shutterstock.com

1. Syrian refugee creates website to thank Israelis

A Sunni Muslim originally from the city of Homs created Thank You Am Israel, a website dedicated to the Israeli and Jewish organizations and people helping Syrian refugees.

2. 9 of the best Israeli snacks

The rising global popularity of Israeli cuisine isnt limited to gourmet fare. Here we tempted your taste buds with Israels most iconic snack foods, such as Bamba and Krembo, getting attention from bloggers and noshers around the world.

3. 9 of the most beautiful sukkot in Israel

Our readers loved seeing photos of the gorgeous booths created for dining during the Sukkot holiday in the fall, from Jerusalems Waldorf Astoria, to kibbutzim in the north and south, to the Samaritan communities of Mount Gerizim and Holon.

4. My Name is Israel

Our downloadable, printable 15-slide exhibition shares the stories of Israeli aid in the wake of international disasters and Israelis helping refugees even citizens of enemy nations and sharing their expertise and knowledge worldwide. This DIY exhibition, still available on our home page, was displayed in creative ways in several countries.

5. Cartilage regeneration on the way for knees, osteoarthritis

CartiHeal, mentioned already in 2013,caused quite a stir among readers for its groundbreaking Agili-C implant to treat cartilage and osteochondral defects in traumatic and osteoarthritic joints. Agili-C has now been implanted in over 500 clinical study patients with knee, ankle, and great toe cartilage lesions in Europe and Israel; clinical studies have begun in 15 US sites.

2017

Israeli actor Gal Gadot as Wonder Woman. Photo: courtesy

When Hurricane Harvey barreled into Texas in August, Israeli NGO, IsraAID rushed to help. The story touched a chord and was shared on Facebook alone more than 260,000 times.

2. 14 things you didnt know about Gal Gadot

2017 was most definitely Gal Gadots year. In fact, so were 2018 and 2019, and 2020 could turn out to be just as successful for this Israeli actor. But it was in 2017 that Gadot first stormed the world with her role as Wonder Woman. Find out how Beyonc helped her get the part.

3. 25 brilliant tech companies to watch in 2017

In January, we asked high-tech experts which companies to watch for in the coming year. They identified many hot growth areas including augmented reality, auto-tech, fintech, clean-tech, drones and digital health. And many of the companies they mentioned have indeed gone on to significant things.

4. 69 fabulous reasons we love Israel

For Independence Day, we put together a slideshow of photographs showing some of the many reasons we love Israel.

5. Test your glucose levels without drawing blood

Integrity Applications developed a glucose monitoring device that allows diabetics and pre-diabetics to track blood sugar levels without the need to prick a finger. The device is now on sale in several locations around the world.

2018

Koolulam mass singalong at the Tower of David Museum, June 2018. Photo by Ricky Rachman

1. 800 Jews, Christians, Muslims sing One Love in Jerusalem

You just cant watch this video without getting goosebumps. Israel social singing sensation Koolulam gathered Jews, Christians and Muslims at the Tower of David Museum in a vocal show of unity coinciding with the Muslim holiday of Eid al-Fitr.

2. Israeli scientists develop implanted organs that wont be rejected

Its the stuff of sci-fi, only its real: Israeli researchers invented the first fully personalized tissue implant, engineered from a small fatty tissue biopsy from the patient. This will make it possible to engineer any kind of tissue implant for any part of the body, without danger of rejection.

3. One drug could treat Alzheimers, MS, Crohns and more

Hebrew University-Hadassah Medical School Prof. David Naor is developing a single drug that could effectively treat incurable inflammatory diseases such as Crohns disease, ulcerative colitis, rheumatoid arthritis and multiple sclerosis as well as neurodegenerative maladies such as Alzheimers disease.

4. 8 of the most anticipated hotels opening in 2018

Youre always on the lookout for exciting new places to stay in Israel, and this list really whet your appetite. Now you can book rooms at (most of) these fabulous hotels in Tel Aviv-Jaffa, the Galilee and the Negev, aside from two that still havent opened.

5. Rescuers turn to Israeli tech to save trapped boys

Maxtech Networks communications technology helped divers free 12 boys and their coach trapped for 11 days in a flooded Thai cave.

2019

REEs prototype vehicle chassis. Photo by Yuval Chen

It is testament to just how successful and admired Israeli TV shows have become worldwide, that our most popular story of the year was about the best Israeli TV. While many Israeli shows have been remade, streaming services have opened up the original Israeli versions to viewers all over the world to great acclaim. Last week, the New York Times named Hatufim (Prisoners of War) the finest international TV show of the decade, and Fauda came in at number eight.

2. Buy fresh unsold food from restaurants

The new SpareEat app that lets restaurants and markets offer surplus food at the end of the day at a huge discount appealed to readers two-fold firstly they get to eat great Israeli restaurant food at a discount, and secondly it reduces food waste. Its a win-win!

3. An Israeli startup is totally reinventing how cars are built

The inventors thought investors would laugh at them when they came up with the revolutionary idea of a flat modular platform, a bit like a skateboard, that houses all the cars major components, but instead they loved it. We wrote about Ree in September. The following month, the company unveiled its flat-chassis technology inside Hino Motors new FlatFormer design.

4. Could immunotherapy treatment from Israel cure cancer?

In January we ran a story on Jerusalem startup Immunovative Therapies, which is developing an immunotherapy that could potentially cure cancer. No surprises why this was popular. The company has conducted dozens of clinical trials, but its still a very long road ahead. Worth watching in future years.

5. 13 reasons you should eat like an Israeli

Large breakfasts, salad with every meal, copious amounts of vegetables and olive oil, a reliance on the Mediterranean diet its no surprise that Israel was #1 on a new ranking of countries with the lowest rate of diet-related deaths worldwide, and #10 on the 2019 Bloomberg Healthiest Country Index. In our article we took a look at the reasons why.

Read the rest here:
The top 45 stories of the decade - ISRAEL21c

Read More...

Global Cell Culture Media Market 2019 Analysis Sigma-Aldrich, Corning (Cellgro), Life Technologies and Thermo Fisher – Business Broker

Wednesday, December 18th, 2019

Global Cell Culture Media Market insights relating to crucial aspects of the Cell Culture Media industry influencing its growth during the forecast period to 2024. It shows the sales of various Cell Culture Media forms of product increasing or declining in various regions and countries. The regional Cell Culture Media analysis provided within the report includes an excellent assessment of geographical niches by all factor-like CAGR and market share, production, and consumption. The Cell Culture Media market is divided into quite a detail for a transparent clarification of key growth areas with leading players that can make the foremost of it.

The Cell Culture Media industry research report additionally ensures the geographical division of this market. The proposed forecast typically includes global market size, share, product demand and supply, market trends, consumer tendencies, profitability, revenue outcomes and also company profiles of the key participants operating in the global Cell Culture Media market. For long-lasting business growth and strategic management, every manufacturer/company peruses intact forecast analysis that drives their business ahead of the curve.significant players of this Cell Culture Media Market are Atlanta Biologicals, Thermo Fisher, Merck Millipore, Zenbio, Sigma-Aldrich, PromoCell, BD, CellGenix, Corning (Cellgro), Life Technologies, GE Healthcare, Lonza, Takara and HiMedia

At the company level, this report focuses on the application, classification, and forecasts pertaining to volume and value, and future predictions for each manufacturer covered in this report. The top-down approaches have been used to counter-validate the Global Cell Culture Media Market numbers, while bottom-up approaches have been used to evaluate the market numbers for each element. The data has been authenticated by using the triangulation method in this exclusive report.

Key Players Of Cell Culture Media Market:

Atlanta Biologicals, Thermo Fisher, Merck Millipore, Zenbio, Sigma-Aldrich, PromoCell, BD, CellGenix, Corning (Cellgro), Life Technologies, GE Healthcare, Lonza, Takara and HiMedia

Product Types Of Cell Culture Media Market:

Serum-free Media, Stem Cell Media and Classical Media & Salts

Cell Culture Media Market isolation based on:

Tissue Culture & Engineering, Gene Therapy, Biopharmaceutical Manufacturing and Cytogenetic

Key regions that operate Cell Culture Media market includes Latin America (Argentina, Brazil, and Colombia), North America (Canada, The United States, and Mexico), Asia-Pacific (China, Japan, Korea, India, South-East Asia, and Thailand), Cell Culture Media market in Europe (Russia, Italy, United Kingdom, Germany, and Italy), The Middle East and Africa (South Africa, UAE, Nigeria, Saudi Arabia, and Egypt). Alongside, consumption value, market share, Cell Culture Media market value, import/export details, price/cost, Cell Culture Media market gross margin analysis and SWOT analysis.

1. Product overview and scope of Cell Culture Media market

2. Revenue and sales of Cell Culture Media by type and application (20192024)

3. Major players in the Cell Culture Media industry

4. Cell Culture Media players/suppliers Profiles and Sales data

5. Marketing strategy analysis and Cell Culture Media development trends

6. Worldwide Cell Culture Media Market effect factor analysis

7. Emerging niche segments and regional Cell Culture Media markets

8. A complete framework analysis, including an assessment of the parent Cell Culture Media industry

9. An empirical assessment of the trajectory of the Cell Culture Media market

1o. Major changes in Cell Culture Media market dynamics

11. Historical, present, and prospective size of the worldwide Cell Culture Media industry from the perspective of both value and volume

12. Understanding The Current Cell Culture Media Market

In conclusion, it is an in-depth research report on Global Cell Culture Media industry. Here, we express our thanks for the support and assistance from industry chain related technical experts and Cell Culture Media marketing engineers during Research Teams survey and interviews.

We have a too many categories research reports like Consumer Goods & Retailing, Agriculture, Food & Beverage, Food Services, Energy & Resources, Manufacturing & Construction, Chemicals & Materials, Transportation & Shipping, Biotechnology, Medical Devices, Pharmaceuticals & Healthcare, Business Services & Administration, IT & Telecom, Textiles, Automobile, Electrical & Electronic Device, Ship Manufacturing, Hotel and Tourism, Petroleum Industry, Trading Industry, Technology, Aerospace & Defense, Entertainment, etc.

Read the rest here:
Global Cell Culture Media Market 2019 Analysis Sigma-Aldrich, Corning (Cellgro), Life Technologies and Thermo Fisher - Business Broker

Read More...

Blue Origin Launches Its First Space Tourism Rocket In Seven Months – And Hopes To Take Humans To Space In 2020 – Forbes

Sunday, December 15th, 2019

This was the company's first launch since May

Jeff Bezos company Blue Origin has successfully launched its New Shepard vehicle for a 12th time, as it continues its efforts to begin launching humans on short jaunts into space.

Today at 12.46 P.M. Eastern Time, the U.S. companys 18-meter tall rocket launched from the companys test site in West Texas on the NS-12 mission. On board was a capsule, designed to one day carry up to six people, but on this occasion outfitted with a variety of experiments and sensors.

After reaching a maximum altitude of 104.5 kilometers, the rocket booster separated from the capsule and the two descended back towards Earth. The booster fired up its engines again and performed a controlled landing back on the ground, while the capsule descended safely and slowly to Earth via parachute. The whole flight lasted about ten minutes.

Congratulations to our New Shepard team, said Ariane Cornell, Director of Astronaut and Orbital Sales for Blue Origin, in a live stream for the launch. Look at that capsule. Man I wish I'd been on board today!

This was the sixth flight for this particular New Shepard vehicle, eclipsing the record of five flights made by its predecessor. This particular rocket has been an operational payload vehicle for several flights, meaning there are no more updates to the system, Blue Origin said in a pre-launch statement.

The booster touched down about seven minutes after launching,

New Shepard is designed to be a space tourism vehicle, taking paying customers on short trips into space lasting several minutes and giving them a brief stint of weightlessness before returning to Earth. Tickets are estimated to cost in the region of $200,000.

Blue Origin, which is also developing an orbital rocket called New Glenn, had hoped to start launching its first humans to space in 2019. However, delays have meant that is now almost certain to be pushed back to at least 2020. The company's last launch came in May 2019, while it has kept most of its plans for these inaugural human flights under wraps for now.

Were never going to fly until were absolutely ready, Blue Origins CEO Bob Smith told CNBC last month. [We] have to go look at all the analysis, and then convince ourselves that were ready to go So it probably will be next year.

On todays flight, however, were a number of commercial payloads, with Blue Origin noting it had now launched payloads for 100 customers. These included a NASA recycling experiment, a space plant experiment, and two art experiments in partnership with the band OK Go.

One of our educational payloads from Columbia University, designed and built by undergraduate students and advised by [astronaut] Dr. Michael Massimino, will study the acute impacts of microgravity environments on cell biology, Blue Origin noted in a pre-launch update. This is crucial for humans living and working in space.

Blue Origin also noted that thousands of postcards written by children were on board the flight, from their non-profit organisation Club for the Future. The Club's mission is to inspire future generations to pursue careers in STEM and help visualize the future of life in space, the company said.

Now Blue Origin will be hoping it can move ever closer to human flights. While no updated timescale for that has yet been released for when those might occur, todays launch and landing is at least another step in that direction.

We've got a couple more flights before we're going to get there, said Cornell.

Read this article:
Blue Origin Launches Its First Space Tourism Rocket In Seven Months - And Hopes To Take Humans To Space In 2020 - Forbes

Read More...

Cell Separation Technology Market Overview, Growth Forecast, Demand and Development Research Report to 2027 – VaporBlash

Sunday, December 15th, 2019

Transparency Market Research (TMR)has published a new report on the globalcell separation technology marketfor the forecast period of 20192027. According to the report, the global cell separation technology market was valued at ~US$ 5 Bnin 2018, and is projected to expand at a double-digit CAGR during the forecast period.

Overview

Cell separation, also known as cell sorting or cell isolation, is the process of removing cells from biological samples such as tissue or whole blood. Cell separation is a powerful technology that assists biological research. Rising incidences of chronic illnesses across the globe are likely to boost the development of regenerative medicines or tissue engineering, which further boosts the adoption of cell separation technologies researchers.

Expansion of the global cell separation technology market is attributed to an increase in technological advancements and surge in investments in research & development, such asstem cellresearch and cancer research. The rising geriatric population is another factor boosting the need for cell separation technologies Moreover, the geriatric population, globally, is more prone to long-term neurological and other chronic illnesses, which, in turn, is driving research to develop treatment for chronic illnesses. Furthermore, increase in the awareness about innovative technologies, such as microfluidics, fluorescent-activated cells sorting, and magnetic activated cells sorting is expected to propel the global cell separation technology market.

Want to know the obstructions to your companys growth in future? Request a PDF sample here

North America dominated the global cell separation technology market in 2018, and the trend is anticipated to continue during the forecast period. This is attributed to technological advancements in offering cell separation solutions, presence of key players, and increased initiatives governments for advancing the cell separation process. However, insufficient funding for the development of cell separation technologies is likely to hamper the global cell separation technology market during the forecast period. Asia Pacific is expected to be a highly lucrative market for cell separation technology during the forecast period, owing to improving healthcare infrastructure along with rising investments in research & development in the region.

Rising Incidences of Chronic Diseases, Worldwide, Boosting the Demand for Cell Therapy

Incidences of chronic diseases such as diabetes, obesity, arthritis, cardiac diseases, and cancer are increasing due to sedentary lifestyles, aging population, and increased alcohol consumption and cigarette smoking. According to the World Health Organization (WHO), 2020, the mortality rate from chronic diseases is expected to reach73%, and in developing counties,70%deaths are estimated to be caused chronic diseases. Southeast Asia, Eastern Mediterranean, and Africa are expected to be greatly affected chronic diseases. Thus, the increasing burden of chronic diseases around the world is fuelling the demand for cellular therapies to treat chronic diseases. This, in turn, is driving focus and investments on research to develop effective treatments. Thus, increase in cellular research activities is boosting the global cell separation technology market.

To Obtain All-Inclusive Information On Forecast Analysis Of Global Market, Request A PDF Brochure Here.

Increase in Geriatric Population Boosting the Demand for Surgeries

The geriatric population is likely to suffer from chronic diseases such as cancer and neurological disorders more than the younger population. Moreover, the geriatric population is increasing at a rapid pace as compared to that of the younger population. Increase in the geriatric population aged above 65 years is projected to drive the incidences of Alzheimers, dementia, cancer, and immune diseases, which, in turn, is anticipated to boost the need for corrective treatment of these disorders. This is estimated to further drive the demand for clinical trials and research that require cell separation products. These factors are likely to boost the global cell separation technology market.

According to the United Nations, the geriatric population aged above 60 is expected to double 2050 and triple 2100, an increase from962 millionin 2017 to2.1 billionin 2050 and3.1 billion2100.

Productive Partnerships in Microfluidics Likely to Boost the Cell Separation Technology Market

Technological advancements are prompting companies to innovate in microfluidics cell separation technology. Strategic partnerships and collaborations is an ongoing trend, which is boosting the innovation and development of microfluidics-based products. Governments and stakeholders look upon the potential in single cell separation technology and its analysis, which drives them to invest in the development ofmicrofluidics. Companies are striving to build a platform utilizing their expertise and experience to further offer enhanced solutions to end users.

Stem Cell Research to Account for a Prominent Share

Stem cell is a prominent cell therapy utilized in the development of regenerative medicine, which is employed in the replacement of tissues or organs, rather than treating them. Thus, stem cell accounted for a prominent share of the global market. The geriatric population is likely to increase at a rapid pace as compared to the adult population, 2030, which is likely to attract the use of stem cell therapy for treatment. Stem cells require considerably higher number of clinical trials, which is likely to drive the demand for cell separation technology, globally. Rising stem cell research is likely to attract government and private funding, which, in turn, is estimated to offer significant opportunity for stem cell therapies.

Biotechnology & Pharmaceuticals Companies to Dominate the Market

The number of biotechnology companies operating across the globe is rising, especially in developing countries. Pharmaceutical companies are likely to use cells separation techniques to develop drugs and continue contributing through innovation. Growing research in stem cell has prompted companies to own large separate units to boost the same. Thus, advancements in developing drugs and treatments, such as CAR-T through cell separation technologies, are likely to drive the segment.

As per research, 449 public biotech companies operate in the U.S., which is expected to boost the biotechnology & pharmaceutical companies segment. In developing countries such as China, China Food and Drug Administration(CFDA) reforms pave the way for innovation to further boost biotechnology & pharmaceutical companies in the country.

Global Cell Separation Technology Market: Prominent Regions

North America to Dominate Global Market, While Asia Pacific to Offer Significant Opportunity

In terms of region, the global cell separation technology market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the global market in 2018, followed Europe. North America accounted for a major share of the global cell separation technology market in 2018, owing to the development of cell separation advanced technologies, well-defined regulatory framework, and initiatives governments in the region to further encourage the research industry. The U.S. is a major investor in stem cell research, which accelerates the development of regenerative medicines for the treatment of various long-term illnesses.

The cell separation technology market in Asia Pacific is projected to expand at a high CAGR from 2019 to 2027. This can be attributed to an increase in healthcare expenditure and large patient population, especially in countries such as India and China. Rising medical tourism in the region and technological advancements are likely to drive the cell separation technology market in the region.

Launching Innovative Products, and Acquisitions & Collaborations Key Players Driving Global Cell Separation Technology Market

The global cell separation technology market is highly competitive in terms of number of players. Key players operating in the global cell separation technology market include Akadeum Life Sciences, STEMCELL Technologies, Inc., BD, Bio-Rad Laboratories, Inc., Miltenyi Biotech, 10X Genomics, Thermo Fisher Scientific, Inc., Zeiss, GE Healthcare Life Sciences, PerkinElmer, Inc., and QIAGEN.

These players have adopted various strategies such as expanding their product portfolios launching new cell separation kits and devices, and participation in acquisitions, establishing strong distribution networks. Companies are expanding their geographic presence in order sustain in the global cell separation technology market. For instance, in May 2019, Akadeum Life Sciences launched seven new microbubble-based products at a conference. In July 2017, BD received the U.S. FDAs clearance for its BD FACS Lyric flow cytometer system, which is used in the diagnosis of immunological disorders.

Excerpt from:
Cell Separation Technology Market Overview, Growth Forecast, Demand and Development Research Report to 2027 - VaporBlash

Read More...

Why Virgin Galactic Stock Just Jumped Another 11% – Nasdaq

Tuesday, December 10th, 2019

What happened

Virgin Galactic (NYSE: SPCE) stock had a pretty great day on Monday, shooting up 16% by the closing bell. Credit for that goes to Morgan Stanley, which yesterday initiated coverage of the space tourism stock with an overweight rating and a $22 price target.

Today, Virgin Galactic shares are up again -- rising 12.2% by 10:20 a.m. And I suspect credit for this spike in share price goes to the media, which reported on Morgan Stanley's rating.

Image source: Getty Images.

Just a glance at news reports on the stock "initiation" will tell you why: Morgan Stanley urged investors to "buy the stock," said Barron's. Virgin Galactic "stock can jump 203%," reported Business Insider. Virgin Galactic "shares to triple," predicted CNBC. And who wouldn't want to buy a stock that's set to triple?

I mean, if Virgin Galactic stock is set to go up "203%" but gained "only" 16% yesterday, that means there's still another 187% to go, right?

Well, not so fast.

Yes, Morgan Stanley said that it thinks Virgin Galactic shares could triple en route to its target price of $22. But Morgan Stanley also called the company a "biotech-type" stock -- the kind that can produce amazing returns...or go to zero if disaster strikes in the form of a spaceship crash.

Moreover, it's crucial to understand that Morgan Stanley built its buy thesis on the theory that even if all goes well with its space tourism business, Virgin Galactic will eventually evolve into a provider of an entirely different service -- point-to-point hypersonic commercial air travel. That's a technology that could take a decade or more to develop, however, so even if Morgan Stanley is ultimately proven right about the company's long-term future, investors might have to wait a very long time to find that out.

In the meantime, expect Virgin Galactic shares to wobble wildly, because the future is uncertain, and -- so long as there's the risk of a potential spaceship crash -- Virgin Galactic's end is always near.

10 stocks we like better than Virgin Galactic Holdings IncWhen investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Virgin Galactic Holdings Inc wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

*Stock Advisor returns as of December 1, 2019

Rich Smith has no position in any of the stocks mentioned. The Motley Fool owns shares of Virgin Galactic Holdings Inc. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

See original here:
Why Virgin Galactic Stock Just Jumped Another 11% - Nasdaq

Read More...

Every 13th man has a hair transplant according to Bookimed study – PR Web

Sunday, December 1st, 2019

BOSTON (PRWEB) November 28, 2019

Aesthetic tourism is especially developed in Thailand, where 20% of all patients are from abroad. Hair transplant is one out 5 of the most popular surgeries and the most frequently performed cosmetic procedures for men.

Hair transplant: facts and figures

Revolutionary methods of hair plantation

High demand gives rise to great discoveries. Doctors around the world are working on the development of new therapies that will help solve the hair loss issue by minimizing risks and reducing treatment time.

Except for the traditional hair transplant methods as FUE (follicular unit extraction) and FUT (follicular unit transplant), specialists apply stem cell hair restoration and robotic operation.

A doctor chooses the most effective treatment method according to your personal features and test results.

Hair transplant market trends

The hair transplant market is one of the fastest-growing health care specialties. The market size of hair plantation has developed by 64% since 2014, according to ISHRS statistics, and accounts for 6.5 billion USD.

Four factors are affecting the surgical hair restoration market:

1. the increasing number of people who suffer from baldness over the world2. the growing interest in self-care procedures within the Asia Pacific region3. development of minimally invasive and painless hair transplant techniques4. changing lifestyles globally.

Because of the high demand, there are a lot of clinics providing this procedure at different prices. According to Bookimed stats, the lowest hair transplant cost is offered in India and Turkey due to the general price policy within the country and residents' living wage. Patients also choose the UAE, Thailand, and South Korea in the interest of the combination of affordable prices and vacation.

About this study

This research is conducted by the Bookimed team and based on:

About Bookimed

Bookimed is a global platform for matching medical facilities over the globe and arranging the medical trip in the shortest term. Over 300,000 users from almost 30 countries request Bookimed to get treatment assistance each month.

Bookimed is a medical tourism provider that cooperates with 340 medical centers to help each patient receive timely and high-quality health care. The services of this platform are free of charge for patients because all the proceeds Bookimed gets from the partner clinics.

For more information, visit The Treatment blog or follow Bookimed on Facebook and Twitter.

Related Linkshttps://bookimed.com/

Share article on social media or email:

The rest is here:
Every 13th man has a hair transplant according to Bookimed study - PR Web

Read More...

Cell Separation Technology Market Growth Forecast through 2019-2027 with Upcoming Trends and Market Opportunities – Montana Ledger

Thursday, November 21st, 2019

Transparency Market Research (TMR)has published a new report on the globalcell separation technology marketfor the forecast period of 20192027. According to the report, the global cell separation technology market was valued at ~US$ 5 Bnin 2018, and is projected to expand at a double-digit CAGR during the forecast period.

Overview

Cell separation, also known as cell sorting or cell isolation, is the process of removing cells from biological samples such as tissue or whole blood. Cell separation is a powerful technology that assists biological research. Rising incidences of chronic illnesses across the globe are likely to boost the development of regenerative medicines or tissue engineering, which further boosts the adoption of cell separation technologies by researchers.

Expansion of the global cell separation technology market is attributed to an increase in technological advancements and surge in investments in research & development, such asstem cellresearch and cancer research. The rising geriatric population is another factor boosting the need for cell separation technologies Moreover, the geriatric population, globally, is more prone to long-term neurological and other chronic illnesses, which, in turn, is driving research to develop treatment for chronic illnesses. Furthermore, increase in the awareness about innovative technologies, such as microfluidics, fluorescent-activated cells sorting, and magnetic activated cells sorting is expected to propel the global cell separation technology market.

Request PDF Brochure of the Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1925

North America dominated the global cell separation technology market in 2018, and the trend is anticipated to continue during the forecast period. This is attributed to technological advancements in offering cell separation solutions, presence of key players, and increased initiatives by governments for advancing the cell separation process. However, insufficient funding for the development of cell separation technologies is likely to hamper the global cell separation technology market during the forecast period. Asia Pacific is expected to be a highly lucrative market for cell separation technology during the forecast period, owing to improving healthcare infrastructure along with rising investments in research & development in the region.

Rising Incidences of Chronic Diseases, Worldwide, Boosting the Demand for Cell Therapy

Incidences of chronic diseases such as diabetes, obesity, arthritis, cardiac diseases, and cancer are increasing due to sedentary lifestyles, aging population, and increased alcohol consumption and cigarette smoking. According to the World Health Organization (WHO), by 2020, the mortality rate from chronic diseases is expected to reach73%, and in developing counties,70%deaths are estimated to be caused by chronic diseases. Southeast Asia, Eastern Mediterranean, and Africa are expected to be greatly affected by chronic diseases. Thus, the increasing burden of chronic diseases around the world is fuelling the demand for cellular therapies to treat chronic diseases. This, in turn, is driving focus and investments on research to develop effective treatments. Thus, increase in cellular research activities is boosting the global cell separation technology market.

Increase in Geriatric Population Boosting the Demand for Surgeries

The geriatric population is likely to suffer from chronic diseases such as cancer and neurological disorders more than the younger population. Moreover, the geriatric population is increasing at a rapid pace as compared to that of the younger population. Increase in the geriatric population aged above 65 years is projected to drive the incidences of Alzheimers, dementia, cancer, and immune diseases, which, in turn, is anticipated to boost the need for corrective treatment of these disorders. This is estimated to further drive the demand for clinical trials and research that require cell separation products. These factors are likely to boost the global cell separation technology market.

According to the United Nations, the geriatric population aged above 60 is expected to double by 2050 and triple by 2100, an increase from962 millionin 2017 to2.1 billionin 2050 and3.1 billionby 2100.

Productive Partnerships in Microfluidics Likely to Boost the Cell Separation Technology Market

Technological advancements are prompting companies to innovate in microfluidics cell separation technology. Strategic partnerships and collaborations is an ongoing trend, which is boosting the innovation and development of microfluidics-based products. Governments and stakeholders look upon the potential in single cell separation technology and its analysis, which drives them to invest in the development ofmicrofluidics. Companies are striving to build a platform by utilizing their expertise and experience to further offer enhanced solutions to end users.

Stem Cell Research to Account for a Prominent Share

Stem cell is a prominent cell therapy utilized in the development of regenerative medicine, which is employed in the replacement of tissues or organs, rather than treating them. Thus, stem cell accounted for a prominent share of the global market. The geriatric population is likely to increase at a rapid pace as compared to the adult population, by 2030, which is likely to attract the use of stem cell therapy for treatment. Stem cells require considerably higher number of clinical trials, which is likely to drive the demand for cell separation technology, globally. Rising stem cell research is likely to attract government and private funding, which, in turn, is estimated to offer significant opportunity for stem cell therapies.

Biotechnology & Pharmaceuticals Companies to Dominate the Market

The number of biotechnology companies operating across the globe is rising, especially in developing countries. Pharmaceutical companies are likely to use cells separation techniques to develop drugs and continue contributing through innovation. Growing research in stem cell has prompted companies to own large separate units to boost the same. Thus, advancements in developing drugs and treatments, such as CAR-T through cell separation technologies, are likely to drive the segment.

As per research, 449 public biotech companies operate in the U.S., which is expected to boost the biotechnology & pharmaceutical companies segment. In developing countries such as China, China Food and Drug Administration(CFDA) reforms pave the way for innovation to further boost biotechnology & pharmaceutical companies in the country.

Global Cell Separation Technology Market: Prominent Regions

North America to Dominate Global Market, While Asia Pacific to Offer Significant Opportunity

In terms of region, the global cell separation technology market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the global market in 2018, followed by Europe. North America accounted for a major share of the global cell separation technology market in 2018, owing to the development of cell separation advanced technologies, well-defined regulatory framework, and initiatives by governments in the region to further encourage the research industry. The U.S. is a major investor in stem cell research, which accelerates the development of regenerative medicines for the treatment of various long-term illnesses.

The cell separation technology market in Asia Pacific is projected to expand at a high CAGR from 2019 to 2027. This can be attributed to an increase in healthcare expenditure and large patient population, especially in countries such as India and China. Rising medical tourism in the region and technological advancements are likely to drive the cell separation technology market in the region.

Launching Innovative Products, and Acquisitions & Collaborations by Key Players Driving Global Cell Separation Technology Market

The global cell separation technology market is highly competitive in terms of number of players. Key players operating in the global cell separation technology market include Akadeum Life Sciences, STEMCELL Technologies, Inc., BD, Bio-Rad Laboratories, Inc., Miltenyi Biotech, 10X Genomics, Thermo Fisher Scientific, Inc., Zeiss, GE Healthcare Life Sciences, PerkinElmer, Inc., and QIAGEN.

These players have adopted various strategies such as expanding their product portfolios by launching new cell separation kits and devices, and participation in acquisitions, establishing strong distribution networks. Companies are expanding their geographic presence in order sustain in the global cell separation technology market. For instance, in May 2019, Akadeum Life Sciences launched seven new microbubble-based products at a conference. In July 2017, BD received the U.S. FDAs clearance for its BD FACS Lyric flow cytometer system, which is used in the diagnosis of immunological disorders.

Global Cell Separation Technology Market: Segmentation

Cell Separation Technology Market by Technology

Cell Separation Technology Market by Application

Cell Separation Technology Market by End User

Cell Separation Technology Market by Region

Visit link:
Cell Separation Technology Market Growth Forecast through 2019-2027 with Upcoming Trends and Market Opportunities - Montana Ledger

Read More...

Costa Rica sets the foundations with development potential in the Fourth Industrial Revolution – Q Costa Rica News

Friday, November 8th, 2019

What is known as the Fourth Industrial Revolution will bring about the disappearance and transformation of thousands of jobs; At the same time, it will give great emphasis to information and communication technologies.

However, there will be other areas with great potentials, such as biotechnology and medical research, where Costa Rica could become a hub in the future if it seizes the opportunity.

Costa Rica has the human talent to carry it out and to initiate a bioreactivation of the economy; However, decision-makers have not yet seen the opportunity, says Miguel Rojas, a researcher at the Biotechnology Research Center of the Instituto Tecnolgico de Costa Rica (Technological Institute of Costa Rica).

And in this area of science, innovative technologies such as precision and regenerative medicine will be applied, as well as tissue engineering and RNA and stem cell-based therapies.

Immunotherapy and advanced diagnoses would also have a place in this wave of job creation and economic recovery.

The engineers and biotechnology engineers (IBio) of the TEC have the appropriate training and ability to work with these methodologies. The paradox, in this case, is that the country has the human talent for these new processes, but the decision-makers at the political, business or financial level have not realized this enormous possibility for the country, said Rojas.

Currently, there are 608 TEC graduates, which represent one in 40 applicants who wanted to study it, so the system itself guarantees the excellence of human talent.

On the other hand, it is estimated that about 20 million medical tourism patients every year, according to the specialized guide of Patients Beyond Borders.

One of the biggest demand for this business is from Americans, with some 1.9 million traveling outside their borders to receive medical care.

Costa Ricas proximity to the United States, cost and human talent make it competitive; In 2018, more than 15,000 people identified health care as their main reason for travel, to the country according to the Instituto Costarricense de Turismo (ICT) Costa Rican Tourism Board so there is plenty of room to grow.

As for medical research, biotechnology would have multiple applications in the future, says the Organization for Economic Cooperation and Development (OECD).

Costa Rica has a great opportunity in clinical research for us to sell or develop sponsored by pharmaceutical houses or with medical equipment producers, taking advantage of the presence in the country of multinationals, said Massimo Manzi, executive director of the Cmara Costarricense de la Salud (Promed) Costa Rican Chamber of Health.

In this way, the country would not only receive designs and produce them, but it would also be fully involved in all the stages of research, development and pre-commercialization of clinical studies.

The Biotechnology career has high expectations, according to the TEC that receives 1,664 applications per year (2016-2018), but only 40 per year are accepted. As of March 2018, the school reports 556 graduates, of which 60% are women, which have potential work in 20 countries on four continents.

Survivors of the revolution

The International Monetary Fund (IMF) said that the robotization of sectors of the economy would displace more than 7 million jobs in the 17 most important economies in the world by 2020.

However, several careers will have a high demand and are the following:

La Repblica reports in Spanish.

Read more from the original source:
Costa Rica sets the foundations with development potential in the Fourth Industrial Revolution - Q Costa Rica News

Read More...

The 901: Landing ‘College GameDay’ is another in a string of wins for Memphis – Commercial Appeal

Wednesday, October 30th, 2019

Autoplay

Show Thumbnails

Show Captions

The 901 is your morning blend of Memphis news and commentary

Good morning from Memphis, where U.S. Rep. Steve Cohen has joined the crowd that's calling for Memphis Light, Gas and Water to switch power providers. But first ...

This Saturday,for the first time, ESPN's popular pre-game show "College GameDay" will be in Memphis, on Memphis' most iconic street, talking about Memphis football.

It'll be a great day for the University of Memphis and a great day for head coach Mike Norvell, who with Justin Fuente (2012-15) gets much of the credit for bringing the Tigers to this moment in its history. Andit'll be an especially great day for the die-hard Tigers fans who have cheered on the hometown team through its highs and lows and especially through thedark, disappointing days of coach Larry Porter (2010-11).

But now, as "College GameDay" put it in a tweet yesterday, "THE WAIT IS OVER!"

Our Jason Munzhas the "College GameDay" news, our Evan Barnes looks at how it happened, and columnist Mark Giannotto explainswhy Tigers fans need to show up at the Liberty Bowl Memorial Stadium onSaturday to see the No. 23 Tigers take on the No. 14 SMU onlythe second time ever that a ranked Tiger football team has hosted another ranked team.

But the meaning of "GameDay" coming to Memphis goes beyond sports.

For too many years, despite its rich history, Memphis was a nationalafterthought. We were that place whereElvis Presley lived and Dr. Martin Luther King Jr. died, seldom mentioned except in relation to basketball or as the home of global shipper FedEx. Our growth was stagnant, andour crime and poverty rates among the highest in the nation. In other words, instead of a "happening" city, Memphis was see as a "happened" city.

That's starting to change, and "GameDay" coming is another step in that direction.

ESPN's "College GameDay" is coming to Memphis Saturday.(Photo: ESPN)

Where Memphis' growth was stagnant before, Downtown Memphis now has more than $4 billion with a "b" in its development pipeline, our Desiree Stennett reports. Memphis is featured every Monday night on prime time thanks to NBC's locally filmedlegal drama "Bluff City Law." Overall, crime seems like it's trending downward and both mayors for the city and Shelby County are eyeing improvements to prekindergarten and public transit that could help lower the area's poverty rate in upcoming years.

I've also argued recently that Memphis Mayor Jim Strickland won reelection because he found a way to tap into the newfound optimism many Memphians feel about their city.

Here's the point: Memphis isn't just having a moment right now it's having lots of them. For all of its problems, there's a very real sense thatthe city has momentum. If this were the chase scene in a movie, Memphis would be at the point where the driver has to decide whether to go pedal to the metal to jump chasm or slam the brakes.

Memphis should floor it:The city should continue investing in itself in its football program, in its growth, in its citizens'safety and education, in its film industry, etc.

Because Memphians love Memphis. And it's time the rest of the world understandwhy.

Speaking of sports: Our Tigers basketball beat reporter Jason Munz has three takeaways from the University of Memphis win yesterday against LeMoyne-Owen. Also, check out our David Cobb's latest on the Grizzlies' 134-133 overtime win Sunday.

April 18, 2019 - U.S. Rep. Steve Cohen talks with media about the Mueller Report while in his office Thursday afternoon.(Photo: Brad Vest/The Commercial Appeal)

Ending the city'slong-time contract to buy power fromthe Tennessee Valley Authority could be Memphis Mayor Jim Strickland's "lottery," U.S. Rep. Steve Cohen recently said.

To understand that sentence, based on this story from our Sam Hardiman, you need context:Cohen, a Democrat from Memphis, carried the legislation that established the state's lottery program when he was a state legislator.And the city is currently studying whether switchingpower providers couldsavehundreds of millions of dollars a year.

Jims got momentum. Jims gonna have the [Mid-South Fairgounds]. Theres going to be some other things that Jim does, but if he can save the people hundreds of millions of dollars on utility costs, thats his lottery, Cohen said.

That's all undoubtedly true if (and it's still an "if" at this point)leaving TVA will really save the citymoney. Strickland made that point in a statement in response:

"I have said since we formed the Power Supply Advisory Team that we would let them work, process all the information, and make a recommendation. That process is not complete, and it would be irresponsible to comment before they finish their work. At the end of the day, we want the most reliable service at the best possible price.

Cohenshould let the process work. Yes, several studies haveshown switching power providers would possiblysave theMemphis Light, Gas and Water Division money. And maybe that's what the Power Supply Advisory Team will conclude.

But until then, this is too important a decision to rush. Or to make political.

Speaking of Cohen: The congressman may have jumped the gun on switching MLGW power providers, but he's right on time with his emphasis on making Memphis streets safer. He recently convened a meeting on pedestrian safety, our Sam Hardiman reports.

"The All-American" Episode 106: Jimmy Smits as Elijah Strait(Photo: NBC, Katherine Bomboy/NBC)

NBC may pull the plug on its"Bluff City Law," but no one seems to have told the people behind the shot-in-Memphis legal drama: The show keeps getting better and better.

Our John Beifuss has the recap of last night's episode, titled "The All-American," about a former hometown football star who wants aphysician-assisted suicide and for the"Conference of Collegiate Athletes" to pay his medical bills. Perhaps even more interesting to Memphians, the show introduces several new filming locations, and included a references to the Memphis Tigers. From John's story:

Although the exploitation of athletes is condemned, football itself isn't criticized; a climactic scene involves a playful backyard game of touch football, with Elijah claiming the right to call his team "University of Memphis Tigers."

Memphis-based Black Bettie, the new project from Joshua Cosby, co-founder of the acclaimed folk duoStar & Micey,released its first self-titled album earlier this month. Fading us out this morning, here's "Poor Kids Millennia":

Like The Fadeout?The 901's Spotify playlist has all of the available featuredsongs from local artists.

Columnist Ryan Poe writes The 901, a running commentary on all things Memphis. Reachhim at poe@commercialappeal.com and on Twitter @ryanpoe.

Want to support local journalism? ACommercial Appeal subscriptiongives you unlimited access to stories and columns. You also get the ability to tap into news from the USA TODAY Network's 109 local sites across the country.

Read or Share this story: https://www.commercialappeal.com/story/news/local/the-901/2019/10/29/901-landing-college-gameday-another-string-wins-memphis/2486857001/

See the rest here:
The 901: Landing 'College GameDay' is another in a string of wins for Memphis - Commercial Appeal

Read More...

8 Small Business Owners On What Its Really Like To Start Your Own Company – Yahoo Lifestyle

Tuesday, October 22nd, 2019

Amy Seder, Co-Founder of Away Lands What is your business?Away Lands is a film and photography production company I founded with my now-fianc. We focus on travel and lifestyle imagery on a wide variety of scales from working with brands, hotels, and tourism boards directly with just the two us, to large full-production commercials. What was it like to go full time with your own business?We made the decision that we were going to change our lives very quickly and surprisingly easily. Brandon and I were living in New York, he worked in finance and I worked in commercial photo productions, and at first we just decided that we wanted to leave and travel full time and really give something unique a try before we settled down into marriage and children. We knew that it would take everything we had, so we set aside a year and a half to plan, build, and save as much as we could before taking off. During that time we got our first couple of film jobs and realized what we were really doing was starting a business. When the time finally came to quit our jobs and leave our apartment, and our whole lives in New York, it was both terrifying and exhilarating!

How long did it take you to turn a profit?We started turning a profit about 7-9 months into working for ourselves full-time, which I know is incredibly lucky! It was easier to be net-positive because we cut our expenses so drastically; we didnt have a car, or our own place to live for the first year, and were able to work enough that our food and travel expenses would be often covered, even if we werent getting paid ourselves. It was after about a year and a half that we felt financially comfortable enough to buy a car and get our own apartment.

What was the hiring process like for your employee?We decided that it was time to hire an assistant about a year ago, when our workload just started to become too overwhelming. We realized the only way to stay on top of it all while continuing to grow would be to outsource and delegate some tasks, and bring in another person to help handle the endless to-do lists. I had had assistants and interns at prior jobs, but never on my own. We came up with a comprehensive list of all of the tasks we wanted an assistant to handle, posted the listing to a few job search sites, and read through hundreds of resumes that came in. We ended up doing phone interviews with about 8-10 candidates, meeting three in person, and ultimately hiring one. As our business covers a lot of different aspects, we looked at a number of people with difference specialties some with more of an art and photography background, some with more of a graphic design and web background, and the assistant we decided to hire had more of a professional business background.

What is a common misconception about small business owners?In our business particular, there are a lot of misconceptions about what we do and who we are. Since a part of my business is social media focused, there are constant opinions about every aspect of influencer culture and endless assumptions about how we never work, dont have a real job, etc. In travel, there can be a glamorous air to being in a different country every couple of weeks and staying in fancy hotels, and I am extremely grateful for the experiences weve had and being able to do this work, but the reality of our job is that we are not vacationing. We are often up before dawn shooting, never stopping, and staying up half the night processing the work and prepping. I love what I do and truly feel like I made up my own dream job, but I really never stop working.

What advice would you give to someone who wants to start their own business?I have stayed in contact with my first boss from my very first "grown-up job" when I was 21, and when we were starting out she told us to, expect to wait 6 months for every payment, and make sure to hire a good lawyer. Both of which have been very true!

Read the original post:
8 Small Business Owners On What Its Really Like To Start Your Own Company - Yahoo Lifestyle

Read More...

The Aesthetic Medicine Congress to bring trends in plastic surgery to Dubrovnik – The Dubrovnik Times

Friday, October 11th, 2019

"The Aesthetic Medicine Congress", in collaboration with the British College of Aesthetic Medicine, takes place at the Hotel Palace from October 11 to 13. Top international and local experts will present trends in aesthetic medicine, rejuvenation and facial and body shaping for around 400 announced participants.

In addition to presenting the latest technology and research results, there will also be live demonstrations, interactive panels and lectures on topics ranging from aesthetic medicine to medical tourism.

The Second Congress of Aesthetic Medicine in Dubrovnik, under the high auspices of the President of the Republic of Croatia, Kolinda Grabar-Kitarovic, will be opened by Tourism Minister Gari Cappelli.

Apart from Croatia and the region, participants from Congress come from Britain, Ireland, Italy, Germany, Netherlands, Belgium, Switzerland, France, Greece, USA, Mexico, India, UAE

The famous names of aesthetic medicine are coming to the congrees, such as Raj Kanodia, Tapan Patel, Matt Stefanelli, Bob Khanna, Herve Raspaldo, Tracy Mountford, Tom van Eijk, Iman Nurlin, Dimitris Sykianakis, Ravi Jain and David Ecclestone. The local experts and lecturers are Sinisa Glumicic, Mario Zambelli, Nikola Milojevic, Davor Mijatovic, Zoran Zgaljardic, Tomica Bagatin, Zeljana Bolanca, Aleksandar Milenovic, Mladen Dudukovic and others.

TAMC 2019 is an international aesthetic congress that offers an interactive, evidence-based, multidisciplinary program and provides a platform to encourage the exchange of ideas and experiences, educate, initiate intense discussions, and expand opportunities for new contacts.

TAMC 2019 covers all aspects of aesthetic medicine, and this year's highlights include: anti-aging and face shaping dermal fillers, skin rejuvenation treatments including stem cell and blood plasma treatments, aesthetic gynecology, life extension (gerontology), body shaping and fat reduction, Botulinum toxin type A basic and advanced techniques, complication management, anatomy, cosmetic surgery, cosmetic dentistry, patient communication, business building and marketing, as well as medical tourism.

Here is the original post:
The Aesthetic Medicine Congress to bring trends in plastic surgery to Dubrovnik - The Dubrovnik Times

Read More...

Are Stem Cell Tourism and Other Experimental Treatments …

Tuesday, May 14th, 2019

The stem cells in cord blood are currently approved by the FDA for the treatment of nearly 80 diseases, but they are still showing a lot of promise in a number of other conditions from multiple sclerosis to autism. There is a lot of excitement around the possible future uses of cord tissue, which has stem cells that can become new neural, bone, fat and cartilage tissue and could be utilized in things like sports injuries and severe burns.

Unfortunately, the years between the initial promise shown in these stem cells (especially as they are quick to make headlines) and full FDA approval as a safe and effective therapy has led some people to seek treatments outside current FDA-approved channels. This can involve going to another country to receive a treatment that has yet to be approved in the U.S. or taking part in a treatment that is not a part of an FDA-approved clinical trial.

Drew Pomeranz has made a bit of a comeback after receiving a stem cell infusion for an injury to his elbow

From Peyton Manning reportedly flying to Germany in 2011 for a bulging disk in his neck to Drew Pomeranz receiving an injection in his elbow earlier this year, many have been taking leaps of faith with stem cells treatments outside approved channels. And controversy has followed.

Traveling abroad to receive stem cell treatments outside of those currently approved by the FDA has been getting media attention ever since the promise of stem cell therapies first started making headlines, and these stories are not limited to all-star players either. Earlier this year, a BBC news correspondent said a stem cell therapy in Mexico helped significantly improve the symptoms of her multiple sclerosis, and the Shetland Times has been following one woman who feels a million times better after going to the same country to treat the same condition.

What began with so-called destination healthcare or medical tourism has turned into the recent proliferation of centers in the U.S. practicing what some would consider to be experimental treatments. With them has come an inundation of direct-to-consumer marketing proclaiming benefits that go beyond current research. Let's look at why people have been going outside the scope of FDA-approved treatments and what risks they are taking.

Peyton Manning may be one of the bigger names, and despite the exact outcome being unknown, it definitely added to the exposure the practice was getting earlier this decade. Soter Healthcare, a U.S. facility that specializes in destination healthcare services, says this is because the United States has lagged behind other countries in this field:

For more than 15 years, China has been actively involved in stem cell research, and its scientists and physicians today produce more scholarly papers on the subject than any other nation. In the U.S., stem cell treatment is still years away from approval.

David Mair is the founder of Soter Healthcare and has long advocated the advancements in other countries.

The Chinese, the Germans and the Israelis are among the leaders in the world in stem cell care right now, Mair said in 2011. Today, Mair says the gap has decreased, but we're still lagging behind other nations.

Mair has seen the benefits of going abroad for experimental treatments firsthand. His niece was the subject of a story in the Washington Post in 2010 about her treatment in China for cerebral palsy. The father called the developments unbelievable, and Mair later summed up many of her advancements:

Today, she walks with a single crutch, he said in 2012. She now can use her left-hand independently for major motor skill range of motions. She walks extended distances, her stamina and walking gait are far better, her vision and voice modulate is much better, and she is reading at her grade-level.

Family Guy put the blame on funding although much of its portrayal on the subject, in a typical manner, was over-exaggerated

If this lag in stem cell research in the U.S. is real, it could be because embryonic stem cellsa particular kind of stem cell found in the early stages of gestationand various ethical considerations raised in their use have imbued a bad name on all stem cells. The way Americans feel about embryonic stem cell research went all the way to the White House, with President George Bush, in 2001, limiting research in that category and President Obama later overturning the former presidents order. Regulations, however, still may be hampering progress despite cord bloodderived stem cells, stem cells that form just a little bit later down the road from embryonic stem cells and can be procured with no harm to the baby or child, not having the same ethical considerations or roadblocks.

Dr. Adam Anz of the Andrews Institute for Orthopaedics and Sports Medicine, is one U.S. scientist investigating the benefits of stem cells and is looking into how they could repair cartilage in knee injuries. He is just awaiting FDA approval.

Regulation is good, but that regulation needs to be tailored toward these emerging technologies, said Dr. Anz, who believes the REGROW act in Congress could help create more clinical trials by allowing small clinics and university labs to charge for participation.

The REGROW act would provide parents with better access to trial therapies and lead to accelerated adoption of stem cell treatments.

While people may think they are simply taking advantage of a treatment that has yet to be approved in their country or their situation is so dire that they have nothing to lose, experts warn against procedures that have yet to fully vetted in countries without the proper medical controls. Short- and long-term complications are possible, and there is always the possibility it will make the condition worse or even cause death.

The X-Cell Center is Germany is one institution that seemed to have all the opulent trappings of a well-to-do stem cell treatment center. That was until it was shut down in 2011 by the German government for deaths that occurred in 2010. Since, the X-Cell Center has re-opened in Lebanon under a new name but practicing the same types of treatments.

"Regulatory agencies such as the FDA can ensure that cell therapy that reaches patients is safe (and) effective and that quality control is established for isolating the cells, manipulating them outside of the body, and delivering them," said Jeffrey Karp, director of the Laboratory for Advanced Biomaterials and Stem-Cell-Based Therapeutics at Brigham and Women's Hospital in Cambridge, Massachusetts.

Obtaining adipose-derived stem cells requires a liposuction-like procedure that could feel like a side benefit to some patients

Like Peyton Manning, Chris Johnson, who is a three-time NFL Pro Bowler and once raced a cheetah for a National Geographic segment, also had a stem cell injection. But this one took place in Gulf Breeze, Fla. It is one of many new stem cell clinics in the United States that sidestep FDA regulations by using unadulterated stem cells mainly acquired through the patients adipose fat cells. This is in contrast to similar services in other countries that also use adipose stem cells but multiply their number by some 200 times before re-introducing them back into the body. The FDA warns against treatment using fat-derived stem cells, saying they are being used on the basis of minimal clinical evidence of safety or efficacy, sometimes with the claims that they constitute revolutionary treatments for various conditions.

A study of some of these types of clinics recently made headlines because of their direct-to-consumer advertising practices, which seemed to proclaim stem cells as the cure-all for nearly everything. The FDA now says it is going to crack down on unscrupulous stem cell clinics while easing the path to approval for legitimate treatments.

Mair agrees that these unauthorized clinics need to be shutdown but the FDA needs to be careful to not put restrictions on all clinics for a few bad actors. Mair spoke specifically about a case in Florida where three women were left nearly or totally blind after mesenchymal stem cells from their adipose fat tissue were injected into their eyes.

"We can't allow stuff like what happened to those women in Florida," said Mair. "I'm O.K. with mesenchymal stem cells used in osteoarthritis where global evidence suggests that it is a very strong alternative for people in their 40s and 50s who need a knee replacement," he added.

International Society for Stem Cell Research (ISSCR), a company that, as the name implies, promotes stem cell research proffers these safety tips:

As we see it, stem cell research is still 27 years young and has much further to go. As the FDA process ensures that treatments are safe and effective, we must put faith in its methods even if it causes some delays. The FDA's oversight and tracking of outcomes in stem cell transplantations has led to safer treatment options for everyone, and participation in multiple clinical trials is an important step in proving the safety and efficacy of therapies for the general public. We do realize the some people may feel as though they are in a situation where they cannot wait for full FDA approval. For the rest, we will look for the day when these cord blood and cord tissue transplantations will have gone through the required protocal and be included in the arsenal of standard stem cell treatment options currently available.

More here:
Are Stem Cell Tourism and Other Experimental Treatments ...

Read More...

Stem Cell Tourism and the Political Economy of Hope

Monday, May 13th, 2019

The latest Part of the Journal of Law and Medicine includes the following sections: Editorial: Doctors Suing Patients: Wrestling with Doing No Harm Ian Freckelton QC; Legal Issues: Supporting People with Decision-Making Impairments: Choice, Control and Consumer Transactions Yvette Maker, Bernadette McSherry, Lisa Brophy, Jeannie Marie Paterson and Anna Arstein-Kerslake; Medical Issues: Novel Psychoactive Substances: The Challenges for Health Care, Analytical Science and the Law Victoria Bicknell, Dimitri Gerostamoulos and David Ranson; Bioethical Issues: Taking the Moral Measure of Mental Capacity: Interpretation and Implementation Grant Gillett; and Medical Law Reporter: Public Health Legislation Prohibiting Sports-Embedded Gambling Advertisting Madeleine Farrar and Thomas Faunce.Also in this Part are the following articles: Complementary Health Practitioners Disciplined for Misconduct in Australia 2010-2016 Jenni Millbank, Miranda Kaye, Anita Stuhmcke, David Sibbritt, Isabel Karpin and Jon Wardle; Professional Discipline of the New Zealand Nursing Residential Care Workforce: A Mixed Methods Analysis of HPDT Decisions 2004-2014 Kate Kersey, Kate Diesfeld, Lois J Surgenor and Michael Ip; The Legal System and the Legitimacy of Clinical Guidelines Fiona McDonald; Wastewater Analysis of Substance Use: Implications for Law, Policy and Research Jeremy Prichard, Foon Yin Lai, Emma van Dyken, Phong Thai, Raimondo Bruno, Wayne Hall, Paul Kirkbride, Coral Gartner, Jake OBrien and Jochen F Mueller; Abortion Law in New South Wales: Shifting from Criminalisation to the Recognition of the Reproductive Rights of Women and Girls Christine Forster and Vedna Jivan; Proprietary Rights in Stored Semen: Roblin v Public Trustee and the Commonsense Approach to Stored Human Tissue of Significance Madeline Baker; Treatment of Intersex Children as a Special Medical Procedure Skye ODwyer; Life on the Liminal Bridge Spanning Fertility and Infertility: A Time to Dream and a Time to Decide Pamela M White; Coercive Community Treatment in Mental Health: An Idea Whose Time Has Passed? Sascha Callaghan and Giles Newton-Howes; Blood Libel: An Analysis of Blood Donation Policy As It Affects Gay Men in Australia Edward Davis; Stigma, Homosexuality and the Homosexual Advance Defence Anthony Gray and Kerstin Braun; and The Role of Legal Proxies in End-of-Life Decisions in Italy: A Comparison with Other Western European Countries Denard Veshi and Gerald Neitzke. There are also reviews of the books Patients with Passports: Medical Tourism, Law and Ethics by I Glenn Cohen reviewed by Ian Freckelton QC; and Stem Cell Tourism and the Political Economy of Hope by Alan Petersen, Megan Munsie, Claire Tanner, Casimir MacGregor and Jane Brophy reviewed by Ian Freckelton QC.

View original post here:
Stem Cell Tourism and the Political Economy of Hope

Read More...

‘Stem-cell tourism’ needs tighter controls, say medical …

Thursday, May 9th, 2019

LONDON (Reuters) - Stem-cell tourism involving patients who travel to developing countries for treatment with unproven and potentially risky therapies should be more tightly regulated, international health experts said on Wednesday.

With hundreds of medical centers around the world claiming to be able to repair damaged tissue in conditions such as multiple sclerosis and Parkinson's disease, tackling unscrupulous advertising of such procedures is crucial.

These therapies are advertised directly to patients with the promise of a cure, but there is often little or no evidence to show they will help, or that they will not cause harm, the 15 experts wrote in the journal Science Translational Medicine.

Some types of stem cell transplant mainly using blood and skin stem cells have been approved by regulators after full clinical trials found they could treat certain types of cancer and grow skin grafts for burns patients.

But many other potential therapies are only in the earliest stages of development and have not been approved by international regulators.

"Stem cell therapies hold a lot of promise, but we need rigorous clinical trials and regulatory processes to determine whether a proposed treatment is safe, effective and better than existing treatments," said one of the 15, Sarah Chan of Britain's University of Edinburgh.

The experts called for global action, led by the World Health Organization, to introduce controls on advertising and agree international standards for the manufacture and testing of cell and tissue-based therapies.

"The globalization of health markets and the specific tensions surrounding stem cell research and its applications

have made this a difficult challenge," they wrote. "However, the stakes are too high not to take a united stance."

(Reporting by Kate Kelland, editing by John Stonestreet)

See the rest here:
'Stem-cell tourism' needs tighter controls, say medical ...

Read More...

Page 4«..3456..10..»


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick